Phibro Animal Health Corporation (PAHC)
Return on total capital
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 98,538 | 86,569 | 68,447 | 70,499 | 43,110 | 57,317 | 56,492 | 56,325 | 79,606 | 64,782 | 64,511 | 70,963 | 71,891 | 75,785 | 76,366 | 73,960 | 75,036 | 74,847 | 76,034 | 75,920 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 285,682 | 265,992 | 246,802 | 258,527 | 256,641 | 270,094 | 270,803 | 273,069 | 282,509 | 272,328 | 268,370 | 262,756 | 262,442 | 266,945 | 239,294 | 233,305 | 238,529 | 215,921 | 213,322 | 192,412 |
| Return on total capital | 34.49% | 32.55% | 27.73% | 27.27% | 16.80% | 21.22% | 20.86% | 20.63% | 28.18% | 23.79% | 24.04% | 27.01% | 27.39% | 28.39% | 31.91% | 31.70% | 31.46% | 34.66% | 35.64% | 39.46% |
June 30, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $98,538K ÷ ($—K + $285,682K)
= 34.49%
The analysis of Phibro Animal Health Corporation's return on total capital (ROTC) over the specified period reveals notable fluctuations and underlying trends. As of September 30, 2020, the company exhibited a high ROTC of 39.46%, indicating strong profitability relative to its total capital base at that time. This elevated level reflects effective utilization of capital resources during that period.
Subsequently, there was a consistent decline in ROTC throughout the following years, reaching a low point of 20.63% by September 30, 2023. This downward trend suggests a gradual reduction in the company's efficiency in generating returns from its total capital base over this period. The decline appears to be relatively steady, with some minor fluctuations, such as a slight uptick to 28.18% in June 2023 before decreasing again.
However, in late 2023 and into 2024, the ROTC demonstrates signs of recovery, increasing to 27.27% on September 30, 2024, and further edging upward to 27.73% by December 31, 2024. The upward trajectory continues into 2025, with the ROTC rising to 32.55% on March 31, 2025, and thereafter reaching 34.49% by June 30, 2025, indicating an improvement in the company's overall efficiency and profitability relative to its total capital base.
The overall trend from 2020 to 2025 shows an initial high that gradually diminishes over time, followed by a period of recovery. This pattern may reflect a cycle of operational challenges or strategic shifts within the company, with recent data suggesting a positive turnaround. The fluctuations across the analyzed periods highlight the dynamic nature of the company's profitability measures, influenced potentially by market conditions, operational adjustments, or strategic initiatives affecting capital productivity.
Peer comparison
Jun 30, 2025